Phase 1/2 study of GBS-01 in patients with gemcitabine-refractory advanced pancreatic cancer.
Phase of Trial: Phase I/II
Latest Information Update: 01 Dec 2016
At a glance
- Drugs GBS 01 (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kracie Pharma
- 17 Jan 2013 Status changed from suspended to completed as reported by University Hospital Medical Information Network - Japan.
- 17 Jul 2012 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network - Japan.
- 18 Jun 2011 New trial record